ANAVEX LIFE SCIENCES CORP.(AVXL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
AVXL Stock Analysis & AI Quality Score
AI stock analysis and institutional research for ANAVEX LIFE SCIENCES CORP. (AVXL), a Healthcare sector company. AVXL is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), ANAVEX LIFE SCIENCES CORP. reports net income of $-5.7M, free cash flow of $-7.2M. Top institutional holders of AVXL by reported 13-F value include BlackRock,, STATE STREET, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. AVXL trades on the Nasdaq exchange and files with the SEC under CIK 1314052. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVXL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ANAVEX LIFE SCIENCES CORP. directly from SEC EDGAR.
Net Income
Q1 2026
$-5.7M
Free Cash Flow
Q1 2026
$-7.2M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Net Income
+9.5% YoYOperating Income
+5.2% YoYEPS (Diluted)
+13.3% YoYTotal Assets
-12.2% YoYOp. Cash Flow
-10.9% YoY| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-43.0M +9.5% | $-47.5M +1.0% | $-48.0M -26.6% | $-37.9M -44.2% | $-26.3M +0.1% | $-26.3M |
| Operating Income | $-52.9M +5.2% | $-55.8M -9.4% | $-51.0M -21.4% | $-42.0M -35.1% | $-31.1M | — |
| EPS (Diluted) | $-0.52 +13.3% | $-0.60 +3.2% | $-0.62 -14.8% | $-0.54 | — | — |
| Total Assets | $135.6M -12.2% | $154.4M +1.1% | $152.7M -5.5% | $161.6M +367.9% | $34.5M +36.4% | $25.3M |
| Operating Cash Flow | $-30.8M -10.9% | $-27.8M -14.6% | $-24.2M +20.2% | $-30.4M -42.7% | $-21.3M -14.9% | $-18.5M |
Get alerted when AVXL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for ANAVEX LIFE SCIENCES CORP. including:
Top Institutional Holders of AVXL
BlackRock, Inc.
$23.4M7,609,618 shSTATE STREET CORP
$13.9M4,512,028 shVANGUARD CAPITAL MANAGEMENT LLC
$11.9M3,863,950 shTWO SIGMA INVESTMENTS, LP
$10.0M3,247,888 shGEODE CAPITAL MANAGEMENT, LLC
$6.7M2,188,275 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$3.1M995,663 shSummit Financial, LLC
$2.9M940,455 shBANK OF AMERICA CORP /DE/
$2.6M863,150 shGOLDMAN SACHS GROUP INC
$2.5M804,435 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.4M783,148 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $23.4M | 7,609,618 |
| STATE STREET CORP | $13.9M | 4,512,028 |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.9M | 3,863,950 |
| TWO SIGMA INVESTMENTS, LP | $10.0M | 3,247,888 |
| GEODE CAPITAL MANAGEMENT, LLC | $6.7M | 2,188,275 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.1M | 995,663 |
| Summit Financial, LLC | $2.9M | 940,455 |
| BANK OF AMERICA CORP /DE/ | $2.6M | 863,150 |
| GOLDMAN SACHS GROUP INC | $2.5M | 804,435 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.4M | 783,148 |
More Healthcare Companies
View all Healthcare →Put AVXL on your watchlist
Track score changes the day ANAVEX LIFE SCIENCES CORP. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AVXL a good stock to buy?
13F Pro's AI-powered analysis of ANAVEX LIFE SCIENCES CORP. (AVXL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AVXL are available on the AVXL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own AVXL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AVXL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ANAVEX LIFE SCIENCES CORP.'s investment landscape.